Location: Lake CIty

404 NW Hall of Fame Drive

Lake City, FL 32055

Tel: (386) 868-5625

Fax: (877)-592-8370

Study evaluating the efficacy, safety, and pharmacokinetics of LX9211 in Patients With Diabetic Peripheral Neuropathic Pain (RELIEF-DPN 1)

This is a phase 2 study evaluating the efficacy and safety of a low and high dose of study LX9211 compared to placebo in patients with moderate to severe diabetic peripheral neuropathy.

Location(s): Jacksonville- LaVilla (Downtown), Lake CIty, Macon

Condition: Diabetic Peripheral Neuropathy

Study to Assess Effectiveness of GlaxoSmithKline’s (GSK’s) Meningococcal Group B and Combined ABCWY Vaccines in Healthy Adolescents and Young Adults.

The purpose of this study is to evaluate the effectiveness of 2 doses or 3 doses of GSK’s licenced meningococcal group B Bexsero (rMenB+OMV NZ) vaccine and of 2 doses of GSK’s investigational combined meningococcal (MenABCWY) vaccine (GSK3536819A) in healthy adolescents and young adults.

Location(s): Lake CIty

Condition: Vaccine

Inclisiran in Patients With Cardiovascular Disease (ORION-4)

A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease

Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Lake CIty, Macon, St. Augustine

Condition: Cholesterol, Heart Disease